Figure 3.
FFP rates in 500 patients with HL at CS IA and IIA. Group A+B was 42 patients with LPHL plus 144 with cHL without MI; group C included 314 patients cHL with MI (P log-rank A+B versus C was not significant).
FFP rates in 500 patients with HL at CS IA and IIA. Group A+B was 42 patients with LPHL plus 144 with cHL without MI; group C included 314 patients cHL with MI (P log-rank A+B versus C was not significant).
